Molecular Characterization of Patients Affected by Williams Syndrome and Autism.

CompletedOBSERVATIONAL
Enrollment

6

Participants

Timeline

Start Date

September 30, 2014

Primary Completion Date

November 30, 2015

Study Completion Date

December 31, 2015

Conditions
Williams Beuren SyndromeAutism Spectrum Disorder
Interventions
GENETIC

chromosomal microarray analysis (CMA) and whole exome sequencing (WES)

"The investigator evaluated the following hypotheses:~i) atypically large 7q11.23 deletions including additional genes; ii) rare pathogenic variants in genes located within the deletion, in particular GTF2I iii) additional pathogenic copy number variants (CNVs) or rare intragenic pathogenic variants located in other chromosomal regions with various inheritance patterns (autosomal recessive, X-linked, de novo autosomal dominant); given the small number of patients recruited, we focused on rare exonic variants considered to be pathogenic according to the criteria of the American College of Medical Genetics and Genomics (ACMG)"

All Listed Sponsors
lead

Hospices Civils de Lyon

OTHER

NCT04095585 - Molecular Characterization of Patients Affected by Williams Syndrome and Autism. | Biotech Hunter | Biotech Hunter